Latest Stock Split Details
Key information about Viracta Therapeutics, Inc.'s most recent stock split
Split Date: 2021-02-25
Split Ratio: 57:200
Price Before Split: $3.85
Price After Split: $1.10
Developer API
Get VIRX split history as JSON
Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.
GETapi.roic.ai/v2/stock-splits/VIRX
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 3.51 times fewer shares (a 57:200 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Viracta Therapeutics, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2021-02-25 | 57:200 | Yes | $3.85 | $1.10 |
| 2020-09-03 | 1:10 | Yes | $0.14 | $0.01 |
| 2016-09-08 | 1:6 | Yes | $0.74 | $0.12 |
| 2011-02-15 | 1:6 | Yes | $0.11 | $0.02 |
About Viracta Therapeutics, Inc.
Company overview and industry information
Viracta Therapeutics, Inc. (VIRX) operates in the Biotechnology industry. The recent 57-for-200 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Viracta Therapeutics, Inc. Summary